Arcadia Biosciences, Inc. (NASDAQ:RKDA) Short Interest Update

Arcadia Biosciences, Inc. (NASDAQ:RKDAGet Free Report) saw a large decrease in short interest in September. As of September 15th, there was short interest totalling 26,100 shares, a decrease of 13.3% from the August 31st total of 30,100 shares. Currently, 4.3% of the company’s stock are short sold. Based on an average daily volume of 8,700 shares, the short-interest ratio is presently 3.0 days.

Arcadia Biosciences Stock Down 0.4 %

Shares of NASDAQ RKDA opened at $2.72 on Monday. Arcadia Biosciences has a twelve month low of $1.85 and a twelve month high of $3.93. The company has a market cap of $3.70 million, a PE ratio of -0.53 and a beta of 1.34. The business’s 50 day moving average price is $2.82 and its two-hundred day moving average price is $2.68.

Arcadia Biosciences (NASDAQ:RKDAGet Free Report) last posted its earnings results on Tuesday, August 13th. The basic materials company reported $0.78 earnings per share for the quarter, missing analysts’ consensus estimates of $1.27 by ($0.49). Arcadia Biosciences had a negative return on equity of 57.51% and a negative net margin of 127.29%. The business had revenue of $1.31 million for the quarter, compared to analyst estimates of $0.95 million. During the same period in the previous year, the firm posted ($2.64) earnings per share. As a group, research analysts anticipate that Arcadia Biosciences will post -1.7 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the stock. HC Wainwright reissued a “buy” rating and issued a $6.00 target price on shares of Arcadia Biosciences in a research note on Wednesday, August 21st. StockNews.com assumed coverage on shares of Arcadia Biosciences in a research report on Saturday. They issued a “sell” rating for the company.

Check Out Our Latest Stock Report on Arcadia Biosciences

Arcadia Biosciences Company Profile

(Get Free Report)

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.

See Also

Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.